In a landmark moment for science and public health, South African scientists have begun the first-ever human trial of an AIDS vaccine developed entirely on African soil.
The groundbreaking trial is being conducted at the Desmond Tutu HIV Foundation in Cape Town, involving 20 volunteers. The study will assess the vaccine’s safety and its ability to trigger a strong immune response.
With nearly eight million people living with HIV/AIDS, South Africa remains the most affected country globally — making this development a potential game-changer not just for South Africa, but for the entire African continent.
Beyond the science, the trial represents a powerful shift:
👉 Africa designing, developing, and testing solutions to its own health challenges.
Hope is rising — cautiously, scientifically, and boldly.
Post a Comment